Ganiraju Manyam
Ganiraju Manyam
Senior BioAnalyst, Department of Bioinformatics & Computational Biology, The UT MD Anderson Cancer
Verified email at mdanderson.org - Homepage
Title
Cited by
Cited by
Year
The consensus molecular subtypes of colorectal cancer
J Guinney, R Dienstmann, X Wang, A De Reynies, A Schlicker, ...
Nature medicine 21 (11), 1350, 2015
23802015
Molecular profiling reveals biologically discrete subsets and pathways of progression in diffuse glioma
M Ceccarelli, FP Barthel, TM Malta, TS Sabedot, SR Salama, BA Murray, ...
Cell 164 (3), 550-563, 2016
11682016
Randomized trial of irinotecan and cetuximab with or without vemurafenib in BRAF-mutant metastatic colorectal cancer (SWOG S1406)
S Kopetz, KA Guthrie, VK Morris, HJ Lenz, AM Magliocco, D Maru, Y Yan, ...
Journal of Clinical Oncology 39 (4), 285-294, 2021
227*2021
CD30 expression defines a novel subset of diffuse large B-cell lymphoma with favorable prognosis and distinct gene expression signature: a report from The International DLBCL
S Hu, ZY Xu-Monette, A Balasubramanyam, GC Manyam, C Visco, ...
Blood, 2013
1992013
ZKSCAN3 Is a Master Transcriptional Repressor of Autophagy
S Chauhan, JG Goodwin, S Chauhan, G Manyam, J Wang, AM Kamat, ...
Molecular Cell, 2013
1942013
iBAG: integrative Bayesian analysis of high-dimensional multiplatform genomics data
W Wang, V Baladandayuthapani, JS Morris, BM Broom, G Manyam, ...
Bioinformatics 29 (2), 149-159, 2013
1132013
Proteomic characterization and functional analysis of outer membrane vesicles of Francisella novicida suggests possible role in virulence and use as a vaccine
T Pierson, D Matrakas, YU Taylor, G Manyam, VN Morozov, W Zhou, ...
Journal of proteome research 10 (3), 954-967, 2011
1102011
Prevalence and clinical implications of EpsteinBarr virus infection in de novo diffuse large B-cell lymphoma in Western countries
CY Ok, L Li, ZY Xu-Monette, C Visco, A Tzankov, GC Manyam, ...
Clinical Cancer Research 20 (9), 2338-2349, 2014
982014
Androgen receptor inhibitorinduced BRCAness and PARP inhibition are synthetically lethal for castration-resistant prostate cancer
L Li, S Karanika, G Yang, J Wang, S Park, BM Broom, GC Manyam, W Wu, ...
Science signaling 10 (480), 2017
922017
Prognostic impact of concurrent MYC and BCL6 rearrangements and expression in de novo diffuse large B-cell lymphoma
Q Ye, ZY Xu-Monette, A Tzankov, L Deng, X Wang, GC Manyam, C Visco, ...
Oncotarget 7 (3), 2401, 2016
822016
Association of CpG island methylator phenotype and EREG/AREG methylation and expression in colorectal cancer
MS Lee, EJ McGuffey, JS Morris, G Manyam, V Baladandayuthapani, ...
British journal of cancer 114 (12), 1352-1361, 2016
702016
Clinical implications of phosphorylated STAT3 expression in de novo diffuse large B-cell lymphoma
CY Ok, J Chen, ZY Xu-Monette, A Tzankov, GC Manyam, L Li, C Visco, ...
Clinical cancer research 20 (19), 5113-5123, 2014
632014
A pan-cancer analysis reveals high-frequency genetic alterations in mediators of signaling by the TGF-β superfamily
A Korkut, S Zaidi, RS Kanchi, S Rao, NR Gough, A Schultz, X Li, ...
Cell systems 7 (4), 422-437. e7, 2018
622018
Association of SMAD4 mutation with patient demographics, tumor characteristics, and clinical outcomes in colorectal cancer
AM Sarshekeh, S Advani, MJ Overman, G Manyam, BK Kee, ...
PLoS One 12 (3), e0173345, 2017
562017
Dysregulated CXCR4 expression promotes lymphoma cell survival and independently predicts disease progression in germinal center B-cell-like diffuse large B-cell lymphoma
J Chen, ZY Xu-Monette, L Deng, Q Shen, GC Manyam, A Martinez-Lopez, ...
Oncotarget 6 (8), 5597, 2015
552015
Targeting DNA damage response in prostate cancer by inhibiting androgen receptor-CDC6-ATR-Chk1 signaling
S Karanika, T Karantanos, L Li, J Wang, S Park, G Yang, X Zuo, JH Song, ...
Cell reports 18 (8), 1970-1981, 2017
492017
Early gene expression profiles of patients with chronic hepatitis C treated with pegylated interferon‐alfa and ribavirin
ZM Younossi, A Baranova, A Afendy, R Collantes, M Stepanova, ...
Hepatology 49 (3), 763-774, 2009
482009
Primary testicular diffuse large B-cell lymphoma displays distinct clinical and biological features for treatment failure in rituximab era: a report from the International PTL
L Deng, ZY Xu-Monette, S Loghavi, GC Manyam, Y Xia, C Visco, J Huh, ...
Leukemia 30 (2), 361-372, 2016
462016
The kinase TBK1 functions in dendritic cells to regulate T cell homeostasis, autoimmunity, and antitumor immunity
Y Xiao, Q Zou, X Xie, T Liu, HS Li, Z Jie, J Jin, H Hu, G Manyam, L Zhang, ...
Journal of Experimental Medicine 214 (5), 1493-1507, 2017
442017
Clinical features, tumor biology, and prognosis associated with MYC rearrangement and Myc overexpression in diffuse large B-cell lymphoma patients treated with rituximab-CHOP
ZY Xu-Monette, BS Dabaja, X Wang, M Tu, GC Manyam, A Tzankov, Y Xia, ...
Modern Pathology 28 (12), 1555-1573, 2015
442015
The system can't perform the operation now. Try again later.
Articles 1–20